Cargando…
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
Monkeypox is a serious public health issue in tropical and subtropical areas. Antivirals that target monkeypox proteins might lead to more effective and efficient therapy. The F13 protein is essential for the growth and maturation of the monkeypox virus. F13 inhibition might be a viable therapeutic...
Autores principales: | Ali, Yasir, Imtiaz, Hina, Tahir, Muhammad Mutaal, Gul, Fouzia, Saddozai, Umair Ali Khan, ur Rehman, Ashfaq, Ren, Zhi-Guang, Khattak, Saadullah, Ji, Xin-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959752/ https://www.ncbi.nlm.nih.gov/pubmed/36851785 http://dx.doi.org/10.3390/v15020570 |
Ejemplares similares
-
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022) -
Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023) -
Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023) -
Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)